Literature DB >> 24591365

Enhanced antibody responses to an HIV-1 membrane-proximal external region antigen in mice reconstituted with cultured lymphocytes.

T Matt Holl1, Guang Yang, Masayuki Kuraoka, Laurent Verkoczy, S Munir Alam, M Anthony Moody, Barton F Haynes, Garnett Kelsoe.   

Abstract

We have shown that the protective HIV-1 Ab, 2F5, avidly reacts with a conserved mammalian self-Ag, kynureninase, and that the development of B cells specific for the 2F5 epitope is constrained by immunological tolerance. These observations suggest that the capacity to mount Ab responses to the 2F5 epitope is mitigated by tolerance, but such capacity may be latent in the pretolerance and/or anergic B cell pools. In this study, we use B cell tetramer reagents to track the frequencies of B cells that recognize the HIV-1 2F5 epitope (SP62): in C57BL/6 mice, SP62-binding transitional B cells are readily identified in bone marrow but are lost during subsequent development. Unsurprisingly then, immunization with SP62 immunogen does not elicit significant humoral responses in normal C57BL/6 mice. Reconstitution of Rag1(null) mice with normal congenic B cells that have matured in vitro restores the capacity to mount significant serum Ab and germinal center responses to this HIV-1 epitope. These B cell cultures are permissive for the development of autoreactive B cells and support the development of SP62-specific B cell compartments normally lost in 2F5 Ab knockin mice. The recovery of humoral responses to the 2F5/SP62 epitope of HIV-1 by reconstitution with B cells containing forbidden, autoreactive clones provides direct evidence that normal C57BL/6 mice latently possess the capacity to generate humoral responses to a conserved, neutralizing HIV-1 epitope.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24591365      PMCID: PMC4003504          DOI: 10.4049/jimmunol.1302829

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  85 in total

Review 1.  Neutralizing antibodies against HIV -- back in the major leagues?

Authors:  Flavia Ferrantelli; Ruth M Ruprecht
Journal:  Curr Opin Immunol       Date:  2002-08       Impact factor: 7.486

2.  Cutting edge: BLyS enables survival of transitional and mature B cells through distinct mediators.

Authors:  Benjamin L Hsu; Susan M Harless; R Coleman Lindsley; David M Hilbert; Michael P Cancro
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

3.  Identification of an antigen-specific B cell population.

Authors:  Jeffrey Newman; Jeffrey S Rice; Chuansheng Wang; Shannon L Harris; Betty Diamond
Journal:  J Immunol Methods       Date:  2003-01-15       Impact factor: 2.303

4.  Predominant autoantibody production by early human B cell precursors.

Authors:  Hedda Wardemann; Sergey Yurasov; Anne Schaefer; James W Young; Eric Meffre; Michel C Nussenzweig
Journal:  Science       Date:  2003-08-14       Impact factor: 47.728

5.  HIV vaccine design and the neutralizing antibody problem.

Authors:  Dennis R Burton; Ronald C Desrosiers; Robert W Doms; Wayne C Koff; Peter D Kwong; John P Moore; Gary J Nabel; Joseph Sodroski; Ian A Wilson; Richard T Wyatt
Journal:  Nat Immunol       Date:  2004-03       Impact factor: 25.606

Review 6.  Development and selection of marginal zone B cells.

Authors:  Thiago Lopes-Carvalho; John F Kearney
Journal:  Immunol Rev       Date:  2004-02       Impact factor: 12.988

7.  Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes.

Authors:  D A Nemazee; K Bürki
Journal:  Nature       Date:  1989-02-09       Impact factor: 49.962

8.  Analysis of the repertoire of anti-(4-hydroxy-3-nitrophenyl)acetyl (NP) antibodies in C 57 BL/6 mice by cell fusion. II. Characterization of idiotopes by monoclonal anti-idiotope antibodies.

Authors:  M Reth; T Imanishi-Kari; K Rajewsky
Journal:  Eur J Immunol       Date:  1979-12       Impact factor: 5.532

9.  Antibody neutralization and escape by HIV-1.

Authors:  Xiping Wei; Julie M Decker; Shuyi Wang; Huxiong Hui; John C Kappes; Xiaoyun Wu; Jesus F Salazar-Gonzalez; Maria G Salazar; J Michael Kilby; Michael S Saag; Natalia L Komarova; Martin A Nowak; Beatrice H Hahn; Peter D Kwong; George M Shaw
Journal:  Nature       Date:  2003-03-20       Impact factor: 49.962

10.  The immune response against anti-idiotope antibodies. I. Induction of idiotope-bearing antibodies and analysis of the idiotope repertoire.

Authors:  T Takemori; H Tesch; M Reth; K Rajewsky
Journal:  Eur J Immunol       Date:  1982-12       Impact factor: 5.532

View more
  10 in total

Review 1.  Minding the gap: The impact of B-cell tolerance on the microbial antibody repertoire.

Authors:  Joel Finney; Akiko Watanabe; Garnett Kelsoe; Masayuki Kuraoka
Journal:  Immunol Rev       Date:  2019-09-27       Impact factor: 12.988

2.  General Approach for Tetramer-Based Identification of Autoantigen-Reactive B Cells: Characterization of La- and snRNP-Reactive B Cells in Autoimmune BXD2 Mice.

Authors:  Jennie A Hamilton; Jun Li; Qi Wu; PingAr Yang; Bao Luo; Hao Li; John E Bradley; Justin J Taylor; Troy D Randall; John D Mountz; Hui-Chen Hsu
Journal:  J Immunol       Date:  2015-04-17       Impact factor: 5.422

3.  DNA vaccine molecular adjuvants SP-D-BAFF and SP-D-APRIL enhance anti-gp120 immune response and increase HIV-1 neutralizing antibody titers.

Authors:  Sachin Gupta; Emily S Clark; James M Termini; Justin Boucher; Saravana Kanagavelu; Celia C LeBranche; Sakhi Abraham; David C Montefiori; Wasif N Khan; Geoffrey W Stone
Journal:  J Virol       Date:  2015-01-28       Impact factor: 5.103

4.  N-terminal residues of an HIV-1 gp41 membrane-proximal external region antigen influence broadly neutralizing 2F5-like antibodies.

Authors:  Dezhi Li; Jie Liu; Li Zhang; Tianshu Xu; Junheng Chen; Liping Wang; Qi Zhao
Journal:  Virol Sin       Date:  2015-12-21       Impact factor: 4.327

5.  Rescue of HIV-1 broad neutralizing antibody-expressing B cells in 2F5 VH x VL knockin mice reveals multiple tolerance controls.

Authors:  Laurent Verkoczy; Yao Chen; Hilary Bouton-Verville; Jinsong Zhang; Marilyn Diaz; Jennifer Hutchinson; Ying-Bin Ouyang; S Munir Alam; T Matt Holl; Kwan-Ki Hwang; Garnett Kelsoe; Barton F Haynes
Journal:  J Immunol       Date:  2011-09-09       Impact factor: 5.422

6.  Polyreactivity and autoreactivity among HIV-1 antibodies.

Authors:  Mengfei Liu; Guang Yang; Kevin Wiehe; Nathan I Nicely; Nathan A Vandergrift; Wes Rountree; Mattia Bonsignori; S Munir Alam; Jingyun Gao; Barton F Haynes; Garnett Kelsoe
Journal:  J Virol       Date:  2014-10-29       Impact factor: 5.103

7.  Chemically modified peptides based on the membrane-proximal external region of the HIV-1 envelope induce high-titer, epitope-specific nonneutralizing antibodies in rabbits.

Authors:  Vincent J Venditto; Lindsay Wieczorek; Sebastian Molnar; Fernando Teque; Gary Landucci; Douglas S Watson; Donald Forthal; Victoria R Polonis; Jay A Levy; Francis C Szoka
Journal:  Clin Vaccine Immunol       Date:  2014-05-28

8.  BCR and Endosomal TLR Signals Synergize to Increase AID Expression and Establish Central B Cell Tolerance.

Authors:  Masayuki Kuraoka; Pilar B Snowden; Takuya Nojima; Laurent Verkoczy; Barton F Haynes; Daisuke Kitamura; Garnett Kelsoe
Journal:  Cell Rep       Date:  2017-02-14       Impact factor: 9.995

9.  Cross-Reactivity to Kynureninase Tolerizes B Cells That Express the HIV-1 Broadly Neutralizing Antibody 2F5.

Authors:  Joel Finney; Guang Yang; Masayuki Kuraoka; Shengli Song; Takuya Nojima; Laurent Verkoczy; Daisuke Kitamura; Barton F Haynes; Garnett Kelsoe
Journal:  J Immunol       Date:  2019-11-15       Impact factor: 5.426

Review 10.  Poly- and autoreactivity of HIV-1 bNAbs: implications for vaccine design.

Authors:  Joel Finney; Garnett Kelsoe
Journal:  Retrovirology       Date:  2018-07-28       Impact factor: 4.602

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.